Aventor set up to provide integrated advice:
This article was originally published in Clinica
A new company, Aventor, has been set up to provide medical technology companies integrated, single source solutions to a range of regulatory, reimbursement and political issues. "Whether it is understanding the German and US DRG systems, or meshing the variety of post-market reporting regimes into a single management framework, today's strategic vision needs to be global, integrated and seamless," says Maria Donawa, who supervises the Washington-based company's Rome, London and Berlin offices.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.